Results 111 to 120 of about 29,694 (216)

A Challenging Case of Advanced Cardiac Sarcoidosis Refractory to Infliximab Therapy

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Cardiac sarcoidosis can be life‐threatening, and lack of response to immunosuppressive therapy remains a significant challenge in active disease. We present a case of refractory cardiac sarcoidosis despite third‐line immunosuppression (infliximab). Ongoing multimodality assessment is essential for managing refractory cardiac sarcoidosis.
Manal Ibrahim, Mansimran Singh Dulay, Kshama Wechalekar, Vasileios Kouranos, Rakesh Sharma   +4 more
wiley   +1 more source

Atorvastatin‐Associated Severe Bradyarrhythmia Following Multiorgan Dysfunction: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Statins are the primary treatment for hypercholesterolemia and a cornerstone of atherosclerotic cardiovascular disease prevention. Although generally safe, serious adverse effects may occur in selected patients, particularly when statins are used at high doses or without medical supervision.
Xiao‐Qing Kou, Yan‐Zhen Wang, Yi‐Rong Gan, Yun‐Long Zhang, Shu‐Yun He, Zheng Zhang   +5 more
wiley   +1 more source

Impella‐Assisted High‐Risk Percutaneous Coronary Intervention in Cardiogenic Shock With Low‐Flow, Low‐Gradient Aortic Stenosis and Multivessel Coronary Artery Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Patients with cardiogenic shock, low‐flow, low‐gradient aortic stenosis, and multivessel coronary artery disease who are ineligible for surgery present a major therapeutic challenge. Percutaneous mechanical circulatory support may facilitate revascularization in this high‐risk population. A 69‐year‐old man presented after a mechanical fall and
Douni Roger, Waleed Shaker, Zan Siddiqi, George Abela   +3 more
wiley   +1 more source

Mortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States—Pre‐ and Post‐COVID‐19 Pandemic Perspective (1999−2023)

Clinical Cardiology, Volume 49, Issue 8, August 2026.
From 1999 to 2023, national HF‐substance abuse‐related mortality rates in adults rose over 10‐fold, disproportionately affecting males, older adults, and NH White and NH Black populations. Geographically, nonmetropolitan areas and the Midwestern/Northwestern regions saw the highest burden, signaling an urgent need for integrated cardiovascular and ...
Emad Uddin Sajid, Ayesha Irfan, Muhammad Kashan, Syed Rayyan Ahmed, Muhammad Hasnain Azeem, Tooba Ali, Mabel Waqar, Muneeba Khan, Erum Shahzadi Malik, Md Ariful Haque   +9 more
wiley   +1 more source

Factors Predicting Diuretic Resistance in Patients With Acute Decompensated Heart Failure. [PDF]

J Clin Med Res
Soerarso R, Hasanah DY, Yonas E, Pratama AP, Raharjo SB, Siswanto BB, Cramer MJM, van der Harst P, Oerlemans MIFJ.   +8 more
europepmc   +1 more source

Serum Albumin Modifies the Prognostic Meaning of BNP in Acute Decompensated Heart Failure

Clinical Cardiology, Volume 49, Issue 8, August 2026.
Population: 293 patients hospitalized with acute decompensated heart failure (ADHF); BNP and serum albumin measured at admission. Question: Does serum albumin change how BNP predicts an adverse in‐hospital course? Method: Multivariable logistic regression with an albumin × ln(BNP) interaction term, adjusted for age, sex, systolic blood pressure, eGFR ...
Muneera O. AlTaweel, Elbadri I. Abdelgadir, Lulwah Al Turki, Ramy I. Abulikailik, Fahad Alharbi, Khamess O. Khamees, Waleed Gado   +6 more
wiley   +1 more source

Association of polycythemia with outcomes of acute decompensated heart failure: A matched and weighted cohort analysis. [PDF]

PLoS One
Perets S, Minha S, Maymon SL, Kalmanovich E, Moravsky G, Minha I, Grupper A, Fuchs S, Marcus G.   +8 more
europepmc   +1 more source

Tumor‐infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions

Cancer, Volume 132, Issue 15, 1 August 2026.
Abstract In the past 15 years, immunotherapy has become a major strategy for cancer therapy. Tumor‐infiltrating lymphocyte (TIL) therapy has been under investigation for nearly four decades and received its first Food and Drug Administration approval in 2024, when lifileucel was approved for patients with previously treated metastatic melanoma.
Shen Li, Alexandra E. Rojek, Reid Shaw, Cristina O’Donoghue, J. Michael Millis, Daniel J. Olson   +5 more
wiley   +1 more source

A Rare Presentation of Left Ventricular Noncompaction Cardiomyopathy Revealed by Acute Decompensated Heart Failure. [PDF]

J Med Cases
Sirohi A, Burra S, Pahal S, Mangalesh S, Acero LMR, Nanna M.   +5 more
europepmc   +1 more source

Electroacupuncture Treatment on Sarcopenia in Patients Undergoing Maintenance Haemodialysis: An Effective Therapy

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 4, August 2026.
ABSTRACT Background Electroacupuncture (EA) treatment has been utilized for recovery from neuromuscular‐related diseases and may play a significant role in the treatment of sarcopenia. This interventional, randomized controlled clinical study aims to explore the efficacy of EA treatment in maintenance haemodialysis (MHD) patients with sarcopenia ...
Ruoxin Chen, Qinqin Qian, Bin Wang, Ruoyang Chen, Liuping Zhang, Hui Jin, Jun Zhu, Zuolin Li, Jianyun Gao, Hong Liu   +9 more
wiley   +1 more source